Clinical trial
Effect of Gingko Biloba on the Blood Biomarkers in Mild Cognitive Impairment Patients With Alzheimer's Disease
NCT07579689 is registered in ClinicalTrials.gov with Hanyang University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Gingko Biloba on the Blood Biomarkers in Mild Cognitive Impairment Patients With Alzheimer's Disease
- Lead sponsor
- Hanyang University
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- June 30, 2026
- Completion date
- December 31, 2028
- Enrollment
- 120 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
alzheimer's disease, mild cognitive impairment